1. Introduction {#sec1}
===============

Regenerative medicine and tissue engineering are being revolutionized by the developments in the field of stem cell science. Naturally-derived biomaterials, such as collagen, gelatin, chitin, chitosan, hyaluronate, and alginate, are commonly used in cell culture scaffolds because of their biocompatibility. Recent advances in tissue engineering have enabled the use of naturally-derived biomaterials beyond the regulation of tissue response at the material interface, e.g., in the fabrication of three-dimensional culture matrices [@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7]. However, a major limitation of these materials is quality control; in particular, their microbial safety has not been well characterized and is difficult to control.

Multipotent mesenchymal stem cells (MSCs) are emerging as a desirable tool in regenerative medicine and cell therapy because of their wide-ranging differentiation potential, large expansion capacity, and lack of immune rejection following transplantation. Furthermore, MSCs are widespread in adult organisms, and have been implicated in tissue maintenance and repair, regulation of hematopoiesis, and immunological responses [@bib8]. Human (h)MSCs have applications in tissue engineering, cell-based therapy, and medical devices, but it is unclear how they respond to unfavorable conditions, such as hypoxia or inflammation, after *in vivo* transplantation [@bib9].

Toll-like receptors (TLRs) play an important role in the immune system by participating in the initial recognition of microbial pathogens and pathogen-associated components. TLR agonists can affect the proliferation and differentiation of hMSCs, which express TLRs, such as TLR-4 and the endotoxin receptor [@bib8], [@bib10], [@bib11], [@bib12]. Most TLR agonists are microbial components, e.g., lipoprotein, glycoprotein, double-stranded RNA, non-methylated CpG DNA, flagellin, mycetoma-polysaccharide, and endotoxin, which exerts the greatest biological effect at the lowest dose [@bib13], [@bib14]. Endotoxins are surface lipopolysaccharides (LPS) of gram-negative bacteria and typical pyrogens that elicit host immune responses even when present in trace amounts [@bib13], and have various other biological activities *in vitro* and/or *in vivo* [@bib11], [@bib14].

MSCs differentiate along several lineages via tightly regulated pathways. The human adipose tissue contains cell populations with characteristics similar to the bone marrow stromal cells. Wnt proteins are induced by stimulation by TLR agonists and have been linked to the proliferation and differentiation of various cell types, including MSCs [@bib15]. E.g., endotoxin derived from *Porphyromonas gingivalis* inhibits osteoblast differentiation at doses over 100 ng/ml [@bib16], whereas *Escherichia coli* endotoxin stimulates fibroblast proliferation after 6 d of exposure at concentrations of 50--500 ng/ml [@bib17]. With the exception of CpG DNA, no TLR agonists that affect the proliferation of the human adipose-derived stem cell (hADSCs) are currently known. Endotoxin and peptidoglycans stimulate osteogenic differentiation, whereas CpG DNA inhibits it [@bib9]. In addition, double-stranded RNA analogs do not affect adipogenic or osteogenic differentiation, but act synergistically with endotoxin or peptidoglycan to induce osteogenic differentiation. Pam3Cys, a TLR-2 ligand, inhibits the differentiation of MSCs into osteogenic, adipogenic, and chondrogenic lineages, while preserving their immunosuppressive function [@bib8]. It was also reported that TLR ligands might antagonize MSC differentiation triggered by exogenous mediators and, consequently, support cells in an undifferentiated and proliferative state *in vitro*. Moreover, MSCs derived from a myeloid factor 88-deficient mouse lack the capacity to differentiate into osteogenic and chondrogenic cells [@bib8].

The above reports suggest that TLRs and their ligands are regulators of cell proliferation and differentiation, and contribute to the maintenance of MSC multipotency. Furthermore, these effects differ according to the type of TLR agonist and source of cells. However, it remains unclear why endotoxin would exert different effects on the proliferative and differentiative capacities of each MSC, since the cells recognize it via TLR-4 and activate the same downstream signal transduction pathway. Furthermore, published studies used high concentrations of TLR ligands; this is especially true of endotoxin, which can induce biological responses in the concentration range of pg/ml or ng/ml, depending on the cell type.

Although endotoxin testing is required for the evaluation of the quality and safety of regenerative medicine products derived from the processing of autologous human somatic stem cells [@bib18], as well as pharmaceuticals and medical devices, no reports on the dose response to endotoxin have been published to establish the endotoxin limits for *in vitro* MSC culture systems. Recently, we reported that the *in vitro* proliferation capacity of MSCs is enhanced by endotoxin at concentrations above 0.1 ng/ml, and that up-regulation of Fe/Mn-type superoxide dismutase may improve cell survival during endotoxin exposure [@bib19]. In the current study, we investigated the no-observed-adverse-effect level (NOAEL) of endotoxin for several types of MSCs cultured in media containing various concentrations of endotoxin. We examined the effect of endotoxin on the cellular differentiation capacity and the underlying mechanisms to empirically establish the *in vitro* endotoxin limit for MSC differentiation.

2. Materials and methods {#sec2}
========================

2.1. Reagents and materials {#sec2.1}
---------------------------

Three types of bone marrow-derived hMSCs (hMSC-1: 21-year-old, M/B; hMSC-2: 36-year-old, M/B; hMSC-3: 43-year-old, M/C) and the MSCGM BulletKit, hMSC Osteogenic Differentiation Medium BulletKit, hMSC Adipogenic Differentiation Medium BulletKit, and OsteoImage mineralization assay were purchased from Lonza (Walkersville, MD, USA). Hoechst 33258, BODPY lipid probes, hADSCs (StemPro Human), MesenPRO RS medium kit, StemPro osteogenesis differentiation kit, and StemPro adipogenesis differentiation kit were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Other chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan). All tools made of glass, metal, or Teflon were autoclaved at 250 °C for more than 16 h prior to use.

2.2. Preparation of bacterial endotoxin {#sec2.2}
---------------------------------------

*E. coli* strain O3:K2a, K2b:H3 (ATCC no. 23501; American Type Culture Collection, Manassas, VA, USA) was cultured in a fermenter (50 l) at 37 °C for 16 h with gentle stirring, with an air flow of 1 l/min, in a minimum nutrient broth containing 0.2% (w/v) beef extract, 1% (w/v) peptone, and 0.5% (w/v) NaCl (pH 7.4). After neutralization of the culture medium pH and heat inactivation at 121 °C for 15 min, bacterial cells were collected by continuous centrifugation (7000×*g*) and washed three times with distilled water. This was followed by sequential extraction with ethanol, acetone, and diethyl ether to dehydrate the cells. Endotoxin was extracted from dried cells using the phenol-water method [@bib20], and purified by repeated ultracentrifugation after deoxyribonuclease and ribonuclease treatments [@bib21]. The activity of purified endotoxin was 27.5 EU/ng.

2.3. Cell culture, and analysis of cell proliferation and differentiation {#sec2.3}
-------------------------------------------------------------------------

Three types of bone marrow-derived hMSCs and hADSCs were cultured using the MSCGM BulletKit and MesenPRO RS medium kits, respectively, at 37 °C in a humidified atmosphere containing 5% CO~2~, with a medium exchanged every 3 d. Once the cells reached an 80--90% confluence, they were trypsinized, counted, and passaged. Passage 3 or 4 cells, free of contamination, were used in subsequent experiments. To evaluate the effect of endotoxin on cell differentiation capacity, hMSC-1, hMSC-2, hMSC-3, and hADSC cells were cultured in each differentiation medium in the presence of various concentrations of endotoxin (0.01--100 ng/ml). Cells cultured without endotoxin served as a negative control. Adipogenic differentiation was performed using hMSC Adipogenic Differentiation Medium BulletKit. hMSCs (4.0 × 10^4^ cells/cm^2^) were plated in 96-well plates and cultured in the growth medium. At 100% confluence, the medium was replaced with adipogenic induction medium. Following this, the cells were cultured for 3 days, after which the medium was supplemented with adipogenic maintenance medium for a further 4 days of culturing. After three cycles of induction/maintenance, the cells were cultured for 7--14 days in adipogenic maintenance medium, with the medium being replaced every 2--3 days. Osteogenic differentiation was performed using Osteogenic Differentiation Medium BulletKit. hMSCs (5.7 × 10^3^ cells/cm^2^) were plated in 96-well plates and grown in a growth medium. After 24 h, the medium was replaced by induction medium. The cells were then cultured for 2--4 weeks, and the medium was changed every 3--4 days. Cell nuclei, hydroxyapatite (HAp), and lipid droplets were stained by using Hoechst 33258, OsteoImage mineralization assay, and BODPY lipid probes, respectively. The number of stained cells and the stained area (μm^2^) were analyzed using BZ-9000 (KEYENCE, Osaka, Japan). The differentiation capacities of osteoblasts and adipocytes were evaluated using the following equations: osteoblast differentiation score (OD score) = (HAp area)/(number of cells), and adipocyte differentiation score (AD score) = (lipid droplet area)/(number of cells), respectively. Data were analyzed by one-way analysis of variance (ANOVA). A post-hoc Tukey\'s test was performed on all datasets that were shown to be significantly different by ANOVA (p \< 0.05).

For the proteomics analysis, hMSC-1 cells were cultured in the presence or absence of endotoxin (1000 ng/ml) for 4 d. This was followed by the extraction and purification of cellular proteins, as described in Section [2.4](#sec2.4){ref-type="sec"}.

2.4. Proteomics analysis {#sec2.4}
------------------------

Cultured hMSC-1 cells were recovered by a conventional trypsin treatment, followed by three washes with phosphate-buffered saline at 37 °C. Cells were mixed with a protein extraction reagent consisting of 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, and 30 mM Tris-HCl (pH 7.5), and maintained for 0.5 h at room temperature (25 °C) before centrifugation (10,000×*g* for 10 min). Cellular protein was semi-purified from the supernatant using the 2D clean-up kit (GE Healthcare Japan, Tokyo, Japan), and the cell pellet was suspended in the protein extraction reagent. Protein concentration was determined using the 2D Quant kit (GE Healthcare Japan). Equal amounts of protein from each sample were transferred to Eppendorf tubes; they were then reduced by tributylphosphine for 1 h, alkylated with iodoacetamide for 1.5 h at room temperature, and digested with Trypsin Gold (mass spectrometry grade; Promega, Tokyo, Japan) in the presence of ProteaseMAX surfactant/trypsin enhancer (Promega) for 5 h, at 37 °C. The digestion mixtures were cleaned up and desalted using an OMIX C18 chip (100 μl; Agilent Technologies, Santa Clara, CA, USA). The adsorbed peptides were eluted with 80% (v/v) acetonitrile and dried in a Speed Vac (Thermo Fisher Scientific). They were then suspended in the same volume of 2% (v/v) acetonitrile containing 0.1% (v/v) trifluoroacetic acid. Samples were analyzed by liquid chromatograph-tandem mass spectrometry (LC-MS/MS) using an LTQ-OrbiTrap-XL instrument (Thermo Fisher Scientific) equipped with a DiNa nano-LC system with an electrospray ionization nanospray interface (KYA TECH Corporation, Tokyo, Japan), a C-18 trap cartridge, and C-18 capillary column (0.1 × 150 mm; Chemicals Evaluation and Research Institute, Saitama, Japan). Purified water containing 0.1% (v/v) trifluoroacetic acid (pump A) and acetonitrile (pump B) were used as eluents, at a flow rate of 300 nl/min at 40 °C. The initial gradient condition of 2% B was maintained for 10 min, then linearly increased to 40% B over 150 min, followed by a linear increase to 80% B in 5 min, when it was held constant for 15 min. MS/MS spectra were automatically acquired using the top three modes of Xcalibur software (Thermo Fisher Scientific). Protein identification and function analysis were carried out with Proteome Discoverer software (Thermo Fisher Scientific) with Mascot (Matrix Science, Tokyo, Japan) and the UniProtKB/Swiss-Prot database. Multivariate analysis was performed with i-RUBY software (Medical ProteoScope, Tokyo, Japan). The multivariate value of each protein was calculated as an expression ratio relative to the negative control (1.00).

3. Results {#sec3}
==========

3.1. Effect of endotoxin on adipocyte differentiation of hMSCs and hADSCs {#sec3.1}
-------------------------------------------------------------------------

hMSCs and hADSC were cultured in the presence or absence of endotoxin, and the effect on adipocyte differentiation was evaluated based on cell number and lipid droplet area ([Fig. 1](#fig1){ref-type="fig"}). The AD scores of hMSC-1 cells cultured for 14 d with different concentrations of endotoxin (0--100 ng/ml) varied only slightly (24.53--33.69) ([Fig. 2](#fig2){ref-type="fig"}a). Similarly, the AD scores of hADSC cells cultured for 7 and 14 d in the presence of various concentrations of endotoxin, did not vary significantly ([Fig. 2](#fig2){ref-type="fig"}). On the other hand, the AD score of hMSC-1 cells was significantly higher (p \< 0.05) in the high dose group (100 ng/ml) than in the control group (0 ng/ml) after 7 d of exposure; the scores of hMSC-2 and 3 cells were significantly lower (p \< 0.05) in the high dose groups (1, 10, or 100 ng/ml for hMSC-2; 100 ng/ml for hMSC-3) than in the control groups after 14 d ([Fig. 2](#fig2){ref-type="fig"}). Although the differences were statistically significant, the actual change of the numerical values was not pronounced. These observations suggested that the adipocyte differentiation capacity of hMSCs and hADSCs slightly varied depending on the cell types and culture conditions, but it might not be affected by endotoxin because of the slight change of the AD scores observed.Fig. 1Evaluation of cell differentiation by staining. Nuclei (a), lipid droplets (b), and HAp (c) were stained using Hoechst 33258, BODPY lipid probes, and OsteoImage mineralization assay, respectively.Fig. 2Effect of endotoxin on hMSC adipocyte differentiation. Adipocyte differentiation scores (AD scores) of hMSC-1 (a), hMSC-2 (b), hMSC-3 (c), and hADSC (d) cells cultured for 7 or 14 d in media containing various endotoxin concentrations. AD score = (lipid droplet area)/(number of cells). Data are presented as the mean ± SD (*n* = 4); \*p \< 0.05 vs. the control (0 ng/ml) group.

3.2. Effect of endotoxin on osteoblast differentiation of hMSCs and hADSCs {#sec3.2}
--------------------------------------------------------------------------

*In vitro* osteoblast differentiation of hMSCs and hADSCs was performed in an osteoblast induction medium in the presence of various concentrations of endotoxin. The effect of endotoxin on osteogenic differentiation was evaluated based on the HAp area and cell number ([Fig. 1](#fig1){ref-type="fig"}). The OD scores of hMSC-1 cells cultured for 21 d with different concentrations of endotoxin (0--100 ng/ml) varied considerably (0.56--4.12) ([Fig. 3](#fig3){ref-type="fig"}a). The OD scores of hMSC-2 cells cultured for 21 d in the presence of 0--0.1 ng/ml endotoxin were zero, and then increased up to 8.94 in the presence of increasing amounts of endotoxin ([Fig. 3](#fig3){ref-type="fig"}b). The OD scores of hMSC-3 cells cultured in the presence of 0--10 ng/ml endotoxin were also zero, and increased to 4.57 after 21 d in the presence of 100 ng/ml endotoxin ([Fig. 3](#fig3){ref-type="fig"}c). Thus, the osteoblast differentiation capacity of hMSCs was significantly enhanced by endotoxin at concentrations exceeding 1.0 ng/ml, for hMSC-1 cells; 10 ng/ml, for hMSC-2 cells; and 100 ng/ml, for hMSC-3 cells. On the other hand, the osteoblast differentiation capacity of hADSCs was not affected by endotoxin even at the highest concentration tested (100 ng/ml) ([Fig. 3](#fig3){ref-type="fig"}d).Fig. 3Effect of endotoxin on hMSC osteoblast differentiation. Osteoblast differentiation scores (OD scores) of hMSC-1 (a), hMSC-2 (b), hMSC-3 (c), and hADSC (d) cells cultured for 14, 21, or 28 d in media containing various endotoxin concentrations. OD score = (HAp area)/(number of cells). Data are presented as the mean ± SD (*n* = 4); \*p \< 0.05 vs. the control (0 ng/mL) group.

3.3. Proteomic analysis of intracellular proteins in endotoxin-stimulated hMSC {#sec3.3}
------------------------------------------------------------------------------

To identify the molecular mechanism by which endotoxin enhances the osteoblast differentiation capacity of MSCs, proteins of hMSC-1 cells cultured in the presence or absence of 1000 ng/ml endotoxin for up to 4 d were extracted and analyzed by LC-MS/MS shotgun proteomics. In total, 6130 proteins (p \< 0.05) were identified, including ones associated with the immune system and osteogenesis, as well as the Wnt signaling pathway ([Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, [Table 3](#tbl3){ref-type="table"}). The list of identified protein functions is shown in [Fig. 4](#fig4){ref-type="fig"}.Table 1Abbreviated list of osteogenesis proteins induced in hMSCs by endotoxin.Protein IDPeptide countExpression ratio \[LPS(+)/control\]CodeNameScoreDay 1Day 2Day 3Day 4\[Growth factor and the related protein\]FGF2Heparin-binding growth factor 232.0111.3--1.00.2FGFR2Fibroblast growth factor receptor 225.81103.41.4----NED4LE3 ubiquitin-protein ligase NEDD4-like25.5136.2------PHF7PHD finger protein 732.0114.0----0.0SH3G2Endophilin-A154.523.00.61.452.9STA5ASignal transducer and activator of transcription 5A29.4155.719.90.7--STA5BSignal transducer and activator of transcription 5B29.4155.719.90.7--TSC1Hamartin35.622.18.70.511.0AKT3RAC-gamma serine/threonine-protein kinase23.821.32.11.61.7BMR1ABone morphogenetic protein receptor type-1A25.71--∞----CORL2Ladybird homeobox corepressor 1-like protein22.31--7.5----IRS4Insulin receptor substrate 424.91--30.1----UCHL3Ubiquitin carboxyl-terminal hydrolase isozyme L343.02--2.1--116.1AKT1RAC-alpha serine/threonine-protein kinase30.231.21.44.34.0ASTE1Protein asteroid homolog 124.520.9--2.4--CD109CD109 antigen34.711.2--8.1--FGF12Fibroblast growth factor 1226.51----∞--NCK2Cytoplasmic protein NCK219.71----14.5--P55GPhosphatidylinositol 3-kinase regulatory subunit gamma28.51----17.6--P85APhosphatidylinositol 3-kinase regulatory subunit alpha28.52----17.60.4STAT2Signal transducer and activator of transcription 249.03--1.5∞--TWST1Twist-related protein 120.91----3.0--BMP3BBone morphogenetic protein 3b19.61------2.6ESRP1Epithelial splicing regulatory protein 134.811.40.90.2∞ESRP2Epithelial splicing regulatory protein 234.811.40.90.2∞IF2B2Insulin-like growth factor 2 mRNA-binding protein 266.74--1.21.12.2IF2B3Insulin-like growth factor 2 mRNA-binding protein 331.22--0.81.13.2MINTMsx2-interacting protein42.641.10.61.32.0TISBButyrate response factor 127.21------26.1WWP1NEDD4-like E3 ubiquitin-protein ligase WWP122.91------18.0\[Hormonal steroid\]AK1C3Aldo-keto reductase family 1 member C388.942.71.141.83.2AK1C4Aldo-keto reductase family 1 member C450.6222.91.1177.91.3ARIP4Helicase ARIP423.21∞--0.01.8CSN6COP9 signalosome complex subunit 642.123.50.7--∞FKBP4FK506-binding protein 461.123.10.3--2.8MCRMineralocorticoid receptor27.41∞------PGM5Phosphoglucomutase-like protein 552.91∞0.72.81.3PRP6Pre-mRNA-processing factor 627.1211.30.7----SRCAPHelicase SRCAP32.01∞--0.7--GREB1Protein GREB139.221.3172.90.7--MAGABMelanoma-associated antigen 1124.81--4.9----PGRC1Membrane-associated progesterone receptor component 160.831.12.03.60.4AK1C1Aldo-keto reductase family 1 member C1122.371.61.13.11.9AK1C2Aldo-keto reductase family 1 member C2110.252.01.12.21.2ANM1Protein arginine N-methyltransferase 1113.3110.61.02.41.5DHB11Estradiol 17-beta-dehydrogenase 1118.11----6.7--NCOA2Nuclear receptor coactivator 227.11------∞STAM2Signal transducing adapter molecule 236.010.81.3--3.5\[Glutamate\]CMC1Calcium-binding mitochondrial carrier protein Aralar129.123.41.171.40.3GRIK3Glutamate receptor, ionotropic kainate 321.21∞------GRM3Metabotropic glutamate receptor 329.51∞------RIC8ASynembryn-A82.262.01.71.21.2NARG1NMDA receptor-regulated protein 186.341.63.01.81.1PRAF2PRA1 family protein 265.221.22.50.90.9SHAN1SH3 and multiple ankyrin repeat domains protein 140.531.0∞0.01.1CMC2Calcium-binding mitochondrial carrier protein Aralar271.821.50.73.61.1NMDE3Glutamate \[NMDA\] receptor subunit epsilon-326.51----51.6--GRIK5Glutamate receptor, ionotropic kainate 523.11------37.3\[Vitamin D\]ARI1AAT-rich interactive domain-containing protein 1A26.72--74.4--∞NR2C2Nuclear receptor subfamily 2 group C member 229.81------6.9SMRC1SWI/SNF complex subunit SMARCC1115.131.01.10.93.9SP100Nuclear autoantigen Sp-10040.420.11.11.156.8\[GABA\]ACBPAcyl-CoA-binding protein66.632.50.51.20.7ARMETProtein ARMET90.572.60.50.50.7KCTD8BTB/POZ domain-containing protein KCTD847.6348.11.70.91.3\[Ephrin\]EPHA7Ephrin type-A receptor 723.21------7.9\[Hedgehog\]CF170Uncharacterized protein C6orf17024.015.4----0.0DISP1Protein dispatched homolog 135.41--54.3----PTBP2Polypyrimidine tract-binding protein 260.331.32.41.01.3\[Homeobox\]HXA6Homeobox protein Hox-A631.6220.4------ZHX3Zinc fingers and homeoboxes protein 335.7125.5------\[ECM\]ATS5A disintegrin and metalloproteinase with thrombospondin motifs 533.5120.8------ITIH2Inter-alpha-trypsin inhibitor heavy chain H233.0122.80.00.71.8CO1A1Collagen alpha-1(I) chain177.3142.00.70.71.4CO7A1Collagen alpha-1(VII) chain42.2158.60.8----PDLI1PDZ and LIM domain protein 1133.992.20.80.72.5COKA1Collagen alpha-1(XX) chain30.421.38.80.0--COOA1Collagen alpha-1(XXIV) chain27.71--∞0.01.2LAMB2Laminin subunit beta-234.011.3∞0.81.4TENRTenascin-R32.21--0.53.9--CHST9Carbohydrate sulfotransferase 924.41----2.3--CO4A4Collagen alpha-4(IV) chain37.921.31.22.41.2CO6A2Collagen alpha-2(VI) chain149.280.51.32.10.9CO9A3Collagen alpha-3(IX) chain21.31----2.1--COFA1Collagen alpha-1(XV) chain28.621.30.62.51.7ITAVIntegrin alpha-V118.0101.50.82.21.4TSP2Thrombospondin-246.111.00.83.01.2PCOC2Procollagen C-endopeptidase enhancer 230.620.90.91.39.1HPSE2Heparanase-228.41--0.00.7104.5LAMA5Laminin subunit alpha-527.01------3.6\[Wnt signaling\]LRP6Low-density lipoprotein receptor-related protein 633.52∞0.90.00.0SEM7ASemaphorin-7A44.422.4------APCAdenomatous polyposis coli protein30.511.23.5--151.9CYBPCalcyclin-binding protein67.031.04.21.21.3MESD2Mesoderm development candidate 223.110.867.9--1.4PFTK1Serine/threonine-protein kinase PFTAIRE-128.311.03.1----MACF1Microtubule-actin cross-linking factor 1, isoforms 1/2/3/535.920.01.02.11.0PYGO2Pygopus homolog 220.41----4.3--WNT7AProtein Wnt-7a29.31----12.1--GLIS2Zinc finger protein GLIS221.410.0----3.9TFR1Transferrin receptor protein 177.970.71.41.12.0\[Other\]ATS4A disintegrin and metalloproteinase with thrombospondin motifs 418.21∞------CHD9Chromodomain-helicase-DNA-binding protein 932.51∞------NLPNinein-like protein30.31168.8∞50.1--NO66Nucleolar protein 6626.81∞------PCNAProliferating cell nuclear antigen229.7102.51.81.00.9LBNLimbin49.11--10.10.51.2OMDOsteomodulin31.61--6.6----TENC1Tensin-like C1 domain-containing phosphatase27.410.510.80.7--ARSEArylsulfatase E26.01------∞ZNRF2E3 ubiquitin-protein ligase ZNRF226.320.0--1.29.2[^1]Table 2Abbreviated list of immune system proteins induced in hMSCs by endotoxin.Protein IDPeptide countExpression ratio \[LPS(+)/control\]CodeNameScoreDay 1Day 2Day 3Day 4\[Cytokine\]HNRPQHeterogeneous nuclear ribonucleoprotein Q147.6122.40.91.51.0I17RBInterleukin-17 receptor B38.912.71.00.91.6IL16Pro-interleukin-1621.317.5------IL1R1Interleukin-1 receptor type I27.01∞------LKHA4Leukotriene A-4 hydrolase109.3579.40.61.10.6NALP4NACHT, LRR and PYD domains-containing protein 422.716.5------NLF1Nuclear-localized factor 124.51∞------CCR9C---C chemokine receptor type 924.61--∞0.0--GBP2Interferon-induced guanylate-binding protein 233.82--∞--1.5KS6A5Ribosomal protein S6 kinase alpha-528.811.56.5----MAST2Microtubule-associated serine/threonine-protein kinase 228.41--12.7----SENP5Sentrin-specific protease 529.41--3.00.4--UCRPInterferon-induced 17 kDa protein171.15--69.914.925.6CEBPGCCAAT/enhancer-binding protein gamma28.01----44.6--IL6RBInterleukin-6 receptor subunit beta32.01----89.21.3NALP7NACHT, LRR and PYD domains-containing protein 715.01----12.9--PAI1Plasminogen activator inhibitor 169.651.00.52.73.1TYK2Non-receptor tyrosine-protein kinase TYK224.911.0--29.1∞CSDE1Cold shock domain-containing protein E1119.550.81.00.92.5ELAV1ELAV-like protein 184.040.81.00.427.2NAL11NACHT, LRR and PYD domains-containing protein 1132.51------8.0SRCASarcalumenin28.010.90.10.016.5ZCH11Zinc finger CCHC domain-containing protein 1129.12--0.8--43.6\[TLRs\]SIASSialic acid synthase48.123.31.21.81.1TLR1Toll-like receptor 126.51--0.8----TLR3Toll-like receptor 325.11--0.8----TLR4Toll-like receptor 424.713.9--0.1--WDR34WD repeat-containing protein 3420.41--38.3----CNPY4Protein canopy homolog 451.91----52.93.7CD14Monocyte differentiation antigen CD1422.21------35.7ARD1GTP-binding protein ARD-175.321.21.10.92.8\[NF-κB\]FGD2FYVE, RhoGEF and PH domain-containing protein 222.91101.4----1.1NLRX1NLR family member X128.5324.80.00.71.0COMD5COMM domain-containing protein 538.51--3.4----HBZHTLV-1 basic zipper factor33.31--4.9--1.6JIP3C-jun-amino-terminal kinase-interacting protein 331.120.02.00.90.9JIP4C-jun-amino-terminal kinase-interacting protein 439.121.12.0--2.8UB2R2Ubiquitin-conjugating enzyme E2 R231.31--∞--0.0IKBL2NF-kappa-B inhibitor-like protein 227.51----8.1--FERProto-oncogene tyrosine-protein kinase FER23.81----3.4--LYRICProtein LYRIC32.010.51.23.3--NFKB2Nuclear factor NF-kappa-B p100 subunit16.61----130.9--SPSYSpermine synthase95.541.00.52.90.6TNIP1TNFAIP3-interacting protein 137.72----∞∞TRA2BTransformer-2 protein homolog beta127.831.20.82.11.6PAIRBPlasminogen activator inhibitor 1 RNA-binding protein142.750.90.41.32.1NCOA3Nuclear receptor coactivator 331.02--1.31.4∞NLRC3Protein NLRC329.82--1.0--19.9NLRC5Protein NLRC538.830.80.70.62.1\[Other\]IFIT3Interferon-induced protein with tetratricopeptide repeats 349.5442.42.621.2--M4K2Mitogen-activated protein kinase kinase kinase kinase 219.1156.5------NF2IPNFATC2-interacting protein24.015.4----0.0PO210Nuclear pore membrane glycoprotein 21025.31∞0.1----PSME1Proteasome activator complex subunit 1119.672.81.22.12.7SIN3APaired amphipathic helix protein Sin3a30.81∞------SODMSuperoxide dismutase \[Mn\], mitochondrial301.4152.714.15.79.6TRRAPTransformation/transcription domain-associated protein25.31∞------ZBT32Zinc finger and BTB domain-containing protein 3225.6144.6------IFIT1Interferon-induced protein with tetratricopeptide repeats 143.71--20.057.4--IKZF3Zinc finger protein Aiolos26.91--21.8----ITLN2Intelectin-229.41--3.00.4--M3K7Mitogen-activated protein kinase kinase kinase 727.31--9.1----NFAC1Nuclear factor of activated T-cells, cytoplasmic 125.41--25.6----PAWRPRKC apoptosis WT1 regulator protein61.32--2.31.61.2SEM3BSemaphorin-3B26.31--3.1----TACTT-cell surface protein tactile38.01--98.4----TNAP2Tumor necrosis factor, alpha-induced protein 221.111.93.5----TRI56Tripartite motif-containing protein 5633.11--3.7----ZBT43Zinc finger and BTB domain-containing protein 4330.91--6.1----HLAGHLA class I histocompatibility antigen, alpha chain G51.21--1.18.42.6LIRB2Leukocyte immunoglobulin-like receptor subfamily B member 233.61----3.9--NFAC3Nuclear factor of activated T-cells, cytoplasmic 322.41----19.6--REG3GRegenerating islet-derived protein 3 gamma34.81--0.893.3--TBG2Tubulin gamma-2 chain61.711.01.126.389.3MABP1Mitogen-activated protein kinase-binding protein 139.31------14.3[^2]Table 3Abbreviated list of ion homeostasis proteins induced in hMSCs by endotoxin.Protein IDPeptide countExpression ratio \[LPS(+)/control\]CodeNameScoreDay 1Day 2Day 3Day 4AT1B3Sodium/potassium-transporting ATPase subunit beta-340.224.72.60.81.3DPP6Dipeptidyl aminopeptidase-like protein 630.922.20.0----GP143G-protein coupled receptor 14334.414.5------KCAB3Voltage-gated potassium channel subunit beta-324.019.8------KCNA7Potassium voltage-gated channel subfamily A member 743.5125.11.01.21.3KCNC2Potassium voltage-gated channel subfamily C member 225.216.80.92.61.4NALCNSodium leak channel non-selective protein39.81∞119.3--0.0SCLT1Sodium channel and clathrin linker 132.21∞------SCN1ASodium channel protein type 1 subunit alpha26.81∞--∞--SCN2ASodium channel protein type 2 subunit alpha25.31∞--∞--SCN3ASodium channel protein type 3 subunit alpha26.92∞--68.4--SCN3BSodium channel subunit beta-328.5124.80.10.71.2SCN4ASodium channel protein type 4 subunit alpha25.31∞1.4∞--SCN5ASodium channel protein type 5 subunit alpha28.01∞1.2∞--SCN8ASodium channel protein type 8 subunit alpha25.31∞--∞--SCN9ASodium channel protein type 9 subunit alpha25.92∞--∞--SCNAASodium channel protein type 10 subunit alpha25.62∞0.5∞--SCNBASodium channel protein type 11 subunit alpha33.4250.60.12.31.2SCNNGAmiloride-sensitive sodium channel subunit gamma25.72416.50.01.8--SL9A4Sodium/hydrogen exchanger 427.6167.8------UNC79Protein unc-79 homolog26.41∞------WEE2Wee1-like protein kinase 235.812.9------AT2C1Calcium-transporting ATPase type 2C member 132.52--∞20.5--MX1Interferon-induced GTP-binding protein Mx190.971.08.6----RYR3Ryanodine receptor 325.111.296.3----S39ADZinc transporter ZIP1333.61--33.1----WNK3Serine/threonine-protein kinase WNK344.32--32.40.2--ACOCCytoplasmic aconitate hydratase241.2131.01.74.02.4AT2B1Plasma membrane calcium-transporting ATPase 1114.121.11.073.60.5AT2B3Plasma membrane calcium-transporting ATPase 392.811.11.073.60.9AT2B4Plasma membrane calcium-transporting ATPase 4118.850.81.03.21.0CACB3Voltage-dependent L-type calcium channel subunit beta-326.02--0.1247.1--DYSFDysferlin40.221.81.02.91.4TRPC1Short transient receptor potential channel 129.21----103.7--TRPM5Transient receptor potential cation channel subfamily M member 531.01--0.7∞1.3CA2D2Voltage-dependent calcium channel subunit alpha-2/delta-231.31------2.6CAC1DVoltage-dependent L-type calcium channel subunit alpha-1D35.211.40.0--79.7SCN2BSodium channel subunit beta-228.010.90.10.016.5[^3]Fig. 4List of protein functions. Molecular function (a), cellular components (b), and biological processes (c).

The relative abundance of each protein induced by endotoxin stimulation varied, but in general, the immune system and osteogenesis-related proteins were up-regulated. E.g., 1 d after the beginning of the hMSC-1 cell culture, the levels of the following proteins were increased: TLR-4; glutamate receptors GRIK3 and GRM3; cell-surface co-receptor of Wnt/β-catenin signaling (LRP6; plays a pivotal role in bone formation); osteoblast differentiation-regulated proteins CHD9 and NO66; regulator of the insulin-like growth factor signaling pathways PHF7; type I procollagen enhance factor proliferating cell nuclear antigen (PCNA); homeobox proteins HXA6 and ZHX3; cytokines LKHA4, IL1R, and NLF1; steroid receptors FKBP4; ion homeostasis proteins SCN1A, SCN2A, and SCN3A; and NF-κB--related proteins FGD2 and NLRX1. On days 2 and/or 3, the levels of bone morphogenetic-related proteins (BMPR1A and BMP3B), vitamin D-coupled transcription regulation-related factor (ARI1A), estrogen-responsive protein (GREB1), Fe/Mn-type superoxide dismutase (SODM), and nuclear factor NF-κB p100 subunit (NFKB2) were increased. Furthermore, on day 4, the levels of the growth factor and related proteins (ESRP1, MINT, and TISB) were increased.

4. Discussion {#sec4}
=============

In the current study, we investigated the effect of endotoxin on MSC differentiation in an *in vitro* culture system and the underlying mechanism of that effect, to accurately evaluate the risks associated with endotoxin contamination in culture systems used for tissue engineering, and to establish endotoxin limits based on empirical evidence. In a culture system, endotoxin contamination always indicates the presence of live or dead gram-negative bacteria, but it may also indicate the presence of other microbes, such as gram-positive bacteria and fungi. Although the effect of endotoxins on cell culture should be estimated by bacterial cell counts, the detection of endotoxin activity in a system should be interpreted as a reflection of contamination level. It is therefore important to determine admissible limits of endotoxin levels to assure the safety and quality of MSC-based products.

The osteoblast differentiation capacity of hMSCs used in the current study decreased with cellular aging, and, in particular, hMSC-3 cells only produced small amounts of HAp during the culture period. However, the capacity was enhanced by endotoxin in a dose-dependent manner not only in hMSC-1 and hMSC-2 cells but also in hMSC-3 cells. It has been reported that various stressors, including endotoxin, induce the expression of growth factors in hMSC [@bib22]. Fibroblast growth factor (FGF) and related proteins were indeed detected by the proteomics approach in the current study ([Table 1](#tbl1){ref-type="table"}).

The lowest observed adverse effect level for stimulating osteoblast differentiation of hMSCs was 1.0 ng/ml, which was considerably lower than the dose previously reported [@bib9]. The endotoxin preparation method used in the current study resulted in a low-heterogeneity preparation, with most molecules fully acylated [@bib19]. Further, endotoxin is unstable in aqueous solution. Perhaps these explain why a relatively large amount of endotoxin was required to alter the behavior of MSCs, as compared with previous studies that employed a commercially available *E. coli* endotoxin.

The expression of cluster of differentiation (CD)80, CD86, major histocompatibility complex-II, TLR-4, and tumor necrosis factor-α in MSCs was found to be most effectively induced by endotoxin at a concentration of 10 μg/ml [@bib10]. However, the dose seems to be too high for increasing the expression at a molecular level because, in the current study, the differentiation ability of MSCs was perceptibly increased by endotoxin at concentrations exceeding 1 ng/ml, and alteration of the related gene and protein expression levels in MSCs would be expected to be induced by a lower dosage. The ability of endotoxin to enhance MSC differentiation might be beneficial in regenerative medicine; however, since endotoxin may also affect other cellular functions, a concentration limit should be set for MSC cultures to assure their safety and quality. Although the precise amount of endotoxin that affects MSCs at the molecular level remains unclear, an NOAEL of 0.1 ng/ml was established in the current study based on the effect on MSC osteoblast differentiation. The NOAEL for hMSC-1 cells was 0.01 ng/ml when the cells were pre-cultured with endotoxin (100 ng/ml) prior to the culture in osteoblast differentiation medium (data not shown).

Little is known about the effect of endotoxin on MSCs *in vivo*. Several studies on the host response to biomaterials with spiked-in bacterial components, such as endotoxin, have been published [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], but none have focused on their effect on MSCs or the dose response to establish endotoxin limits at specific sites of the body. In the only quantitative analysis published to date, we reported that a collagen sheet containing dried *E. coli* cells implanted into a cranial or femoral defect in rats led to a dose-dependent delay of the osteoanagenesis with a NOAEL of 9.6 EU/mg [@bib28]. This was not observed when an untreated collagen sheet or one containing *Staphylococcus aureus* cells were used. These observations suggested that endotoxin affected the process of osteoanagenesis and that the delayed formation of new bone was caused by the dried cells that suppressed the development of the connective tissue covering the defective areas, as well as the proliferation and differentiation of MSCs (intramembranous ossification), since the pathology analysis did not reveal any osteoclasts or inflammation [@bib28]. Thus, endotoxin exhibits different effects *in vivo* and *in vitro*.

hMSCs give rise to osteoblasts to form bone. The process beings with the differentiation of osteoprogenitor cells into pre-osteoblasts, which eventually develop into mature osteoblasts. Subsequently, the mature osteoblasts will become entombed in an osteoid to become osteocytes. Osteoblast differentiation requires the expression of proteins associated with osteogenesis, immune system, and Wnt signaling. Bone morphogenetic proteins (BMPs) belong to the transforming growth factor-β (TGF-β) superfamily and have been shown to participate in the patterning and specification of several tissues and organs during vertebrate development, as well as to regulate cell growth, apoptosis, and differentiation [@bib29]. Further, they act as osteoinductive growth factors that may induce bone formation *in vivo* and *in vitro*.

In the current study, we observed that endotoxin affects the expression of many osteogenesis-related proteins, such as TRL-4, BMP3B, BMPR1A, FGF2, FGFR2, GREB1, GRIK3, GRM3, and LRP6. BMP3B, also known as growth differentiation factor 10 (GDF10), is a protein that in human is encoded by the *BMP3B* gene [@bib30]. It plays a role in head formation and may have multiple roles in skeletal morphogenesis [@bib30], [@bib31]. BMP3B and BMP3 are regarded as a separate subgroup within the TGF-beta superfamily [@bib30]. Similar to other BMPs, BMP3B is known for its ability to induce bone and cartilage development. BMP receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B, and the type II receptor BMPR2. Overexpression of a constitutively active form of BMPRIA in chicken limb buds suggests that signaling through this receptor also can regulate chondrocyte differentiation [@bib32]. FGF2 exerts both positive and negative effect on the growth and differentiation of MSCs. E.g., it was shown to promote osteoblast differentiation by inducing the osteocalcin gene expression in MSCs and enhancing calcium deposition [@bib33], [@bib34]. GREB1 is up-regulated in cells expressing markers of osteoblast and chondroblast differentiation [@bib35]. The activation of glutamate receptors (GRIK3 and GRM3) regulates osteoblast and osteoclast differentiation and activity [@bib29]. Wnt family proteins regulate many aspects of cell growth, differentiation, function, and death. The Wnt/β-catenin pathway promotes an increase in the bone mass by a number of mechanisms, including the renewal of stem cells, stimulation of preosteoblast replication, induction of osteoblastogenesis, and inhibition of osteoblast and osteocyte apoptosis. Mutations in the gene encoding a Wnt co-receptor, the low-density lipoprotein receptor-related protein 5 (LRP5), are causally linked to the alterations in human bone mass [@bib36]. LRP6 is another cell-surface co-receptor for Wnt signaling, and plays a pivotal role in bone formation. Msx2-interacting nuclear target protein (MINT) synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element in osteoblasts. TLRs play an important role in the immune system by participating in the initial recognition of microbial pathogens and pathogen-associated components. Further, TLR agonists can affect the proliferation and differentiation of hMSCs [@bib8], [@bib10], [@bib11], [@bib12].

In the current study, although the levels of TLR-1 and 3 were not affected by endotoxin exposure, TLR-4 levels increased on day 1, suggesting that all changes in the osteoblast differentiation ability and protein expression in hMSCs originated from signal transduction via TLR-4, an endotoxin receptor. The superoxide dismutase and some cytokine levels were elevated on day 1. Subsequently, the levels of NF-κB--related proteins increased. Furthermore, the presence of endotoxin resulted in the increase in levels of osteogenesis- and vitamin-related proteins, growth factors, etc., and induced Wnt/β-catenin signaling, which promotes bone morphogenesis. These data indicated that endotoxin enhanced the osteoblast differentiation capacity of hMSCs. On the other hand, preliminary DNA array analysis revealed that the expression of genes encoding an LPS-binding protein and alkaline phosphatase was induced upon endotoxin stimulation (data not shown). This indicated poor correlation between proteomics and DNA microarray data for these proteins. However, changes in the levels of TLR, BMP, cytokine, Wnt/β-catenin signaling, vitamin, and NF-κB--related proteins, etc., showed good correlation with the microarray data (data not shown).

The differentiation of MSCs towards adipogenic or osteogenic cells depend on a variety of signaling and transcription factors. On the other hand, several lines of experimental evidence suggest that an inverse correlation exists between adipogenesis and osteogenesis [@bib37]. Indeed, in the current study, endotoxin was shown to affect the differentiation of hMSCs into osteoblasts but not adipocytes, although the detailed mechanism whereby endotoxin promotes the osteoblast differentiation of hMSCs remains unknown. Collectively, the presented data may be used for the specification of endotoxin limit for biomaterials used for osteogenesis. Quantitative analyses to establish the endotoxin limit for the *in vitro* proliferation and differentiation ability of induced pluripotent stem cells, another cell source for regenerative medicine, are currently in progress in our laboratory.

5. Conclusions {#sec5}
==============

The current study constitutes follow-up research for a previous report [@bib19], describing endotoxin specifications for MSC proliferation, with applications in tissue engineering. The NOAEL for the enhancement of osteoblast differentiation capacity, observed in an *in vitro* culture system, was 0.1 ng/ml (2.75 EU/ml). Future studies should focus on determining the limits for the proliferation or differentiation capacity of induced pluripotent stem cells.
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